Year |
Citation |
Score |
2024 |
Surnar B, Shah AS, Park M, Kalathil AA, Kamran MZ, Ramirez Jaime R, Toborek M, Nair M, Kolishetti N, Dhar S. Correction to "Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress". Acs Nano. PMID 39110088 DOI: 10.1021/acsnano.4c09363 |
0.736 |
|
2024 |
Ashokan A, Sarkar S, Kamran MZ, Surnar B, Kalathil AA, Spencer A, Dhar S. Simultaneous targeting of peripheral and brain tumors with a therapeutic nanoparticle to disrupt metabolic adaptability at both sites. Proceedings of the National Academy of Sciences of the United States of America. 121: e2318119121. PMID 38709930 DOI: 10.1073/pnas.2318119121 |
0.608 |
|
2023 |
Kalathil AA, Guin S, Ashokan A, Basu U, Surnar B, Delma KS, Lima LM, Kryvenko ON, Dhar S. Correction to "New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance". Acs Central Science. 9: 1705. PMID 37637725 DOI: 10.1021/acscentsci.3c00920 |
0.623 |
|
2023 |
Kalathil AA, Guin S, Ashokan A, Basu U, Surnar B, Delma KS, Lima LM, Kryvenko ON, Dhar S. New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance. Acs Central Science. 9: 1297-1312. PMID 37521786 DOI: 10.1021/acscentsci.3c00286 |
0.633 |
|
2021 |
Costoya J, Surnar B, Kalathil AA, Kolishetti N, Dhar S. Controlled release nanoplatforms for three commonly used chemotherapeutics. Molecular Aspects of Medicine. 101043. PMID 34920863 DOI: 10.1016/j.mam.2021.101043 |
0.736 |
|
2021 |
Surnar B, Shah AS, Park M, Kalathil AA, Kamran MZ, Ramirez Jaime R, Toborek M, Nair M, Kolishetti N, Dhar S. Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress. Acs Nano. PMID 34355558 DOI: 10.1021/acsnano.0c09553 |
0.738 |
|
2015 |
Kalathil AA, Kumar A, Banik B, Ruiter TA, Pathak RK, Dhar S. New formulation of old aspirin for better delivery. Chemical Communications (Cambridge, England). PMID 26503669 DOI: 10.1039/C5Cc07316B |
0.705 |
|
Show low-probability matches. |